Smart Money · Holder IQ
64.1 / 100
Above median holder quality (percentile 83.1 this quarter).
COCP
Cocrystal Pharma IncNASDAQ
$0.98-1.00%
Close Nov 13, 2026
Reading stored signals…
Healthcare • Biotechnology
Company Quality Grade
Per-share book value with reinvested dividends, and the steadiness of its 40-quarter trend.
As of · Window to
Historical book-value growth with dividends
- Book with dividends · annual growth
- -50.5%
- Consistency of fitted trend · R²
- 0.934
- Recent / whole-window slope
- 1.9×
- COCP
- Whole-window fit
- Recent 12-quarter fit
Quarterly chart values · 41 observations
· 100 indexed · 85.3 per share
· 99.2 indexed · 84.6 per share
· 60.5 indexed · 51.6 per share
· 59.1 indexed · 50.4 per share
· 59.3 indexed · 50.6 per share
· 58 indexed · 49.4 per share
· 61.1 indexed · 52.1 per share
· 60 indexed · 51.2 per share
· 53 indexed · 45.2 per share
· 52.2 indexed · 44.5 per share
· 31.4 indexed · 26.8 per share
· 32.9 indexed · 28 per share
· 32.2 indexed · 27.5 per share
· 31.5 indexed · 26.8 per share
· 10.3 indexed · 8.8 per share
· 10.9 indexed · 9.3 per share
· 10 indexed · 8.5 per share
· 10.3 indexed · 8.8 per share
· 10.5 indexed · 8.9 per share
· 10.2 indexed · 8.7 per share
· 12.2 indexed · 10.4 per share
· 11.7 indexed · 10 per share
· 11.2 indexed · 9.5 per share
· 10.6 indexed · 9.1 per share
· 7.1 indexed · 6.1 per share
· 6.3 indexed · 5.4 per share
· 5.7 indexed · 4.9 per share
· 5 indexed · 4.3 per share
· 4 indexed · 3.4 per share
· 3.5 indexed · 3 per share
· 3 indexed · 2.6 per share
· 2.6 indexed · 2.2 per share
· 2 indexed · 1.7 per share
· 1.5 indexed · 1.2 per share
· 1.1 indexed · 0.9 per share
· 0.8 indexed · 0.7 per share
· 0.6 indexed · 0.5 per share
· 0.7 indexed · 0.6 per share
· 0.5 indexed · 0.5 per share
· 0.4 indexed · 0.3 per share
· 0.1 indexed · 0.1 per share
Basis: total common book, used as the fallback basis for the whole window. Dividends are reinvested at book value.
No decline detected by the published slope-ratio test.
Method, filing sources and publication receipt
The compounder rule requires a top-decile composite, positive slope and no detected decline in the tangible-book eligible pool. Total-common-book fallback rows cannot qualify. Decline means the 90% interval for recent / whole-window slope lies below 1.
Source: SEC first-filed XBRL. Midas Edge API’s published Green Compounders method uses only filings public by the as-of date, split-adjusted shares and the original filed values. Restatements do not replace them. Issuer pools and entity types reflect the SEC submissions captured for this run, not historical classifications at each as-of date.
The primary form fits log book value with reinvested dividends against time. The method checks the starting book and market-cap floors and excludes identified non-reliance/enforcement windows. Its cohort is fixed at capture time, so historical percentiles have capture and survival limits. It does not check audit-opinion going-concern text. This grade is separate from InsiderIQ, HolderIQ and NetCredibility.
Input filings (41 in this window): 0001415889-16-006730; 0001493152-17-003110; 0001493152-17-004965. The links show up to three of the input filings.
Method notes: An additional method qualification is recorded in the publication receipt. An additional method qualification is recorded in the publication receipt. Going-concern audit wording was not evaluated. Missing dividend facts were treated as zero by the published method. No preferred-equity fact was filed; the method used zero. Enforcement findings use records naming the issuer. Share values were adjusted for stock splits. The history contains a large unexplained tangible-book decline.
- Parameters
- pg-g2-params.v36
- Plane
- sha256:b08311b44a364243079bd02d05184590ce1b4a8cecae5ac54eb47e6d8d100282
- Grade row SHA-256
- sha256:5837501ddb16ea608b62755c814dfbab2cc51d20c68a514280c9d43f5720c1b4
- Manifest SHA-256
- sha256:a759396dbafa0c13c8b128c70452c491b5de054e46821a357c30bd15b13ce27f
- Engine SHA-256
- sha256:59cafdcf1cf34b8d7549562af91a81cf1204405ccf03224493f1228e71293258
- Hand-check receipt SHA-256
- sha256:1eb90c6040524e68ca2ed0a0feab58b3e77fa52586a2872887a9be00ed2a52b7
- Market cap
- $13.65Mas of Nov 12, 2026
- 1 month
- -4.8%
- 3 months
- -10.1%
- 1 year
- -11.3%
- 52-week range
- $0.82$1.57
More market facts
- Dividend
- No dividends on record
- Latest-quarter EPS estimate
- -$0.17Quarter ended Sep 30, 2026 · 3 analysts · 0.0% in 30d
- Short interest
- 1.5% of float181.4K shares · settled Oct 30, 2026 · +1.2% since Oct 15, 2026 · FINRA
Estimate history · same fiscal quarter
Quarter ended Sep 30, 2026. Source: Stored analyst estimates.
| Observed / analysts | EPS | Revenue |
|---|---|---|
| 3 analysts | -0.1733 | — |
| 3 analysts | -0.1733 | — |
| 3 analysts | -0.1733 | — |
| 3 analysts | -0.1733 | — |
Dates identify stored observations, not earnings announcements. Gaps do not mean estimates were unchanged. The analyst group and vendor earnings basis may change.
Link an account to see your stake, watchlist and past holdings. Compare changes in earnings expectations with your investment case. These are analyst estimates, not reported results or a prediction of your return.
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $330K
- Net income
- -$9.94M
- Free cash flow
- -$8.15M
- Book value
- $1.04M
- Total debt
- $1.34M
- P/E
- —
- Price / sales
- 41.4×
- Price / book
- 13.1×
- FCF yield
- -59.7%
- Net margin
- -3,011.5%
Trailing twelve-month statements · as of Nov 13, 2026 · multiples on the Nov 12, 2026 market cap
End-of-day close from stored market data, not a live quote.
About Cocrystal Pharma Inc
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.
Read more
The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is a phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, an HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was headquartered in Bothell, Washington.
- Website
- cocrystalpharma.com
- Headquarters
- Bothell, WA, United States
- Employees
- 10
- Listed
- May 19, 2011
- Fiscal year ends
- December
Company profile stored Oct 30, 2026.
Quarterly results
The last 8 fiscal quarters from the latest stored normalized financial statements. These may include restatements. Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 13, 2026 | $105.0K | — | 100.0% | -$3.2M | -$3.2M |
| Mar 2026filed May 15, 2026 | $225.0K | — | — | -$2.4M | -$2.3M |
| Dec 2025filed Mar 31, 2026 | — | — | — | -$2.5M | -$2.4M |
| Sep 2025filed Nov 14, 2025 | — | — | — | -$2.1M | -$2.0M |
| Jun 2025filed Aug 14, 2025 | — | — | — | -$2.1M | -$2.1M |
| Mar 2025filed May 15, 2025 | — | — | — | -$2.3M | -$2.3M |
| Dec 2024filed Mar 31, 2025 | $136.0K | -5.6% | — | -$3.2M | -$3.3M |
| Sep 2024filed Nov 13, 2024 | — | — | — | -$5.0M | -$4.9M |
Balance sheet · cash, debt and near-term obligations
What resources sit beside the obligations? These are balances at each fiscal quarter end, not cash earned during the quarter. Amounts are in USD, the reporting currency.
As of
- Reported cash
- $2.2M
- Reported total debt
- $1.3M
- Current assets
- $3.2M
- Current liabilities
- $2.6M
Vendor filing date:
As of
- Reported cash
- $4.7M
- Reported total debt
- $1.4M
- Current assets
- $5.9M
- Current liabilities
- $2.2M
Vendor filing date:
As of
- Reported cash
- $7.0M
- Reported total debt
- $1.5M
- Current assets
- $8.1M
- Current liabilities
- $2.2M
Vendor filing date:
As of
- Reported cash
- $7.7M
- Reported total debt
- $1.6M
- Current assets
- $8.8M
- Current liabilities
- $1.5M
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare cash and debt across dates when reviewing its reliance on financing. Current assets can include receivables and inventory; current liabilities include bills as well as borrowings. They are not all spendable cash or all debt. These figures alone do not establish the ability to repay.
Source: the latest stored normalized balance sheets, matched to the same security and fiscal end as these income periods. They may include restatements and are not an originally-filed or knowledge-time history. No net debt, coverage ratio or replacement balance is calculated. Read the SEC guide to financial statements for the distinction between balances and cash flows.
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 31, 2026 | — | — | — | -$9.0M | -$8.8M |
| Dec 2024filed Mar 31, 2025 | — | — | — | -$17.9M | -$17.5M |
| Dec 2023filed Mar 28, 2024 | — | — | — | -$18.6M | -$18.0M |
| Dec 2022filed Mar 29, 2023 | — | — | — | -$38.8M | -$38.8M |
| Dec 2021filed Mar 23, 2022 | $5.4M | +169.5% | — | -$14.2M | -$14.2M |
| Dec 2020filed Mar 17, 2021 | $2.0M | -69.3% | -199.6% | -$9.6M | -$9.6M |
Annual cash generation
Does profit turn into cash? Compare COCP’s accounting profit with operating cash flow and capital spending. Amounts are in USD.
Fiscal year ending
- Net income
- -$8.8M
- Operating cash flow
- -$8.2M
- Capital spending
- $12.0K
- Free cash flow
- -$8.2M
Fiscal year ending
- Net income
- -$17.5M
- Operating cash flow
- -$16.5M
- Capital spending
- $8.0K
- Free cash flow
- -$16.5M
Fiscal year ending
- Net income
- -$18.0M
- Operating cash flow
- -$14.7M
- Capital spending
- $118.0K
- Free cash flow
- -$14.8M
Earlier cash-flow years
Fiscal year ending
- Net income
- -$38.8M
- Operating cash flow
- -$21.4M
- Capital spending
- $74.0K
- Free cash flow
- -$21.5M
Fiscal year ending
- Net income
- -$14.2M
- Operating cash flow
- -$12.7M
- Capital spending
- $52.0K
- Free cash flow
- -$12.8M
Fiscal year ending
- Net income
- -$9.6M
- Operating cash flow
- -$9.8M
- Capital spending
- $240.0K
- Free cash flow
- -$10.1M
Link an account to see your stake, watchlist and past holdings. Compare cash generation and investment needs with your thesis. Working capital and non-cash charges can separate profit from cash. Capital spending can reduce free cash flow while earnings rise. For a long or short position, that gap alone does not predict a price move.
Cash-flow source and meaning
Source: Annual financial statements, latest stored vendor-normalized figures. These may include restatements and may differ from the filer’s own XBRL. A filing date is not the knowledge date of this version of the values.
Free cash flow is the vendor’s reported figure, shown only when it agrees with operating cash flow less capital spending recorded as a positive outflow. It is not cash guaranteed for dividends or buybacks, and it does not subtract every financing obligation. Missing or sign-incompatible inputs are not filled in. An unlabelled currency is used only for a confirmed domestic USD filer. These are annual statements, not forecasts or an originally-filed history.
Cash allocation: dividends, shares and debt
Where did COCP’s financing cash go? Compare cash paid as dividends with net share and debt transactions across fiscal years. Amounts are in USD, the reporting currency. These are company-wide totals, not per-share payouts.
Fiscal year ended
Vendor filing date:
- Total financing cash flow
- $5.4M
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- $0.0
- Total financing cash flow
- $0.0
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- -$7.0K
- Total financing cash flow
- $4.0M
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- -$27.0K
- Total financing cash flow
- -$27.0K
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- -$39.0K
- Total financing cash flow
- $38.5M
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- $35.8M
- Net borrowing / repayment
- -$121.0K
- Total financing cash flow
- $35.7M
Link an account to see your stake, watchlist and past holdings. Compare these uses of cash with operating cash generation and the debt on the balance sheet. A negative net share movement means purchases exceeded issuance; it does not give gross buybacks. A dividend or share purchase can be financed with borrowing, and none of these flows guarantees a future payment or price return.
Allocation source and sign conventions
Source: Annual cash-flow statements, latest stored vendor-normalized values for the same security and fiscal year. These can include restatements; a filing date is not the knowledge date of this version.
Dividends are positive cash paid out. For net share transactions, net borrowing and total financing, positive means cash in and negative means cash out. Net share transactions combine issuance and purchases; they are not gross repurchases, a change in shares outstanding, or stock compensation. Total financing includes other flows and is not the sum of just these three lines. Zero means a reported zero. No FX conversion, shareholder-return total or forecast is inferred.
Short-interest history
Reported short positions, stored float percentages and adjusted prices over the same period.
Shares short
Share of float
Adjusted close · USD
Settlement records · 137 observations
Settlement Oct 30, 2026
181,361 shares short
+2,168 shares (+1.2%) vs Oct 15, 2026
1.5% of the stored float. Published Nov 10, 2026.
Settlement Oct 15, 2026
179,193 shares short
+3,947 shares (+2.3%) vs Sep 30, 2026
1.5% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
175,246 shares short
-147,502 shares (-45.7%) vs Sep 15, 2026
1.5% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
322,748 shares short
+204 shares (+0.1%) vs Aug 31, 2026
3.5% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
322,544 shares short
+14,939 shares (+4.9%) vs Aug 14, 2026
Published Sep 10, 2026.
Settlement Aug 14, 2026
307,605 shares short
-80,399 shares (-20.7%) vs Jul 31, 2026
Published Aug 25, 2026.
Settlement Jul 31, 2026
388,004 shares short
-7,019 shares (-1.8%) vs Jul 15, 2026
Published Aug 11, 2026.
Settlement Jul 15, 2026
395,023 shares short
-9,482 shares (-2.3%) vs Jun 30, 2026
Published Jul 24, 2026.
Settlement Jun 30, 2026
404,505 shares short
-5,649 shares (-1.4%) vs Jun 15, 2026
Published Jul 10, 2026.
Settlement Jun 15, 2026
410,154 shares short
+266,986 shares (+186.5%) vs May 29, 2026
Published Jun 25, 2026.
Settlement May 29, 2026
143,168 shares short
-49,514 shares (-25.7%) vs May 15, 2026
Published Jun 9, 2026.
Settlement May 15, 2026
192,682 shares short
-393,740 shares (-67.1%) vs Apr 30, 2026
Published May 27, 2026.
Settlement Apr 30, 2026
586,422 shares short
-401,924 shares (-40.7%) vs Apr 15, 2026
Published May 11, 2026.
Settlement Apr 15, 2026
988,346 shares short
+839,435 shares (+563.7%) vs Mar 31, 2026
Published Apr 24, 2026.
Settlement Mar 31, 2026
148,911 shares short
-65,285 shares (-30.5%) vs Mar 13, 2026
Published Apr 10, 2026.
Settlement Mar 13, 2026
214,196 shares short
-49,644 shares (-18.8%) vs Feb 27, 2026
Published Mar 24, 2026.
Settlement Feb 27, 2026
263,840 shares short
+27,764 shares (+11.8%) vs Feb 13, 2026
Published Mar 10, 2026.
Settlement Feb 13, 2026
236,076 shares short
+34,010 shares (+16.8%) vs Jan 30, 2026
Published Feb 25, 2026.
Settlement Jan 30, 2026
202,066 shares short
+41,719 shares (+26%) vs Jan 15, 2026
Published Feb 10, 2026.
Settlement Jan 15, 2026
160,347 shares short
+28,922 shares (+22%) vs Dec 31, 2025
Published Jan 27, 2026.
Settlement Dec 31, 2025
131,425 shares short
+3,976 shares (+3.1%) vs Dec 15, 2025
Published Jan 12, 2026.
Settlement Dec 15, 2025
127,449 shares short
-11,344 shares (-8.2%) vs Nov 28, 2025
Published Dec 24, 2025.
Settlement Nov 28, 2025
138,793 shares short
-37,609 shares (-21.3%) vs Nov 14, 2025
Published Dec 9, 2025.
Settlement Nov 14, 2025
176,402 shares short
-85,360 shares (-32.6%) vs Oct 31, 2025
Published Nov 25, 2025.
Settlement Oct 31, 2025
261,762 shares short
+14,355 shares (+5.8%) vs Oct 15, 2025
Published Nov 11, 2025.
Settlement Oct 15, 2025
247,407 shares short
-14,241 shares (-5.4%) vs Sep 30, 2025
Published Oct 24, 2025.
Settlement Sep 30, 2025
261,648 shares short
-719,591 shares (-73.3%) vs Sep 15, 2025
Published Oct 9, 2025.
Settlement Sep 15, 2025
981,239 shares short
+940,049 shares (+2,282.2%) vs Aug 29, 2025
Published Sep 24, 2025.
Settlement Aug 29, 2025
41,190 shares short
+13,699 shares (+49.8%) vs Aug 15, 2025
Published Sep 10, 2025.
Settlement Aug 15, 2025
27,491 shares short
+26,574 shares (+2,897.9%) vs Jul 31, 2025
Published Aug 26, 2025.
Settlement Jul 31, 2025
917 shares short
-1,163 shares (-55.9%) vs Jul 15, 2025
Published Aug 11, 2025.
Settlement Jul 15, 2025
2,080 shares short
-2,390 shares (-53.5%) vs Jun 30, 2025
Published Jul 24, 2025.
Settlement Jun 30, 2025
4,470 shares short
-290 shares (-6.1%) vs Jun 13, 2025
Published Jul 10, 2025.
Settlement Jun 13, 2025
4,760 shares short
-8,956 shares (-65.3%) vs May 30, 2025
Published Jun 25, 2025.
Settlement May 30, 2025
13,716 shares short
+7,739 shares (+129.5%) vs May 15, 2025
Published Jun 10, 2025.
Settlement May 15, 2025
5,977 shares short
+5,304 shares (+788.1%) vs Apr 30, 2025
Published May 27, 2025.
Settlement Apr 30, 2025
673 shares short
-5,473 shares (-89%) vs Apr 15, 2025
Published May 9, 2025.
Settlement Apr 15, 2025
6,146 shares short
+4,669 shares (+316.1%) vs Mar 31, 2025
Published Apr 25, 2025.
Settlement Mar 31, 2025
1,477 shares short
+31 shares (+2.1%) vs Mar 14, 2025
Published Apr 9, 2025.
Settlement Mar 14, 2025
1,446 shares short
-14,638 shares (-91%) vs Feb 28, 2025
Published Mar 25, 2025.
Settlement Feb 28, 2025
16,084 shares short
+1,717 shares (+12%) vs Feb 14, 2025
Published Mar 11, 2025.
Settlement Feb 14, 2025
14,367 shares short
-2,035 shares (-12.4%) vs Jan 31, 2025
Published Feb 26, 2025.
Settlement Jan 31, 2025
16,402 shares short
-2,259 shares (-12.1%) vs Jan 15, 2025
Published Feb 11, 2025.
Settlement Jan 15, 2025
18,661 shares short
-9,215 shares (-33.1%) vs Dec 31, 2024
Published Jan 27, 2025.
Settlement Dec 31, 2024
27,876 shares short
+10,344 shares (+59%) vs Dec 13, 2024
Published Jan 10, 2025.
Settlement Dec 13, 2024
17,532 shares short
+10,500 shares (+149.3%) vs Nov 29, 2024
Published Dec 24, 2024.
Settlement Nov 29, 2024
7,032 shares short
-979 shares (-12.2%) vs Nov 15, 2024
Published Dec 10, 2024.
Settlement Nov 15, 2024
8,011 shares short
+6,023 shares (+303%) vs Oct 31, 2024
Published Nov 26, 2024.
Settlement Oct 31, 2024
1,988 shares short
-34,186 shares (-94.5%) vs Oct 15, 2024
Published Nov 11, 2024.
Settlement Oct 15, 2024
36,174 shares short
-23,612 shares (-39.5%) vs Sep 30, 2024
Published Oct 24, 2024.
Settlement Sep 30, 2024
59,786 shares short
-7,269 shares (-10.8%) vs Sep 13, 2024
Published Oct 9, 2024.
Settlement Sep 13, 2024
67,055 shares short
+2,072 shares (+3.2%) vs Aug 30, 2024
Published Sep 24, 2024.
Settlement Aug 30, 2024
64,983 shares short
+7,681 shares (+13.4%) vs Aug 15, 2024
Published Sep 11, 2024.
Settlement Aug 15, 2024
57,302 shares short
-5,728 shares (-9.1%) vs Jul 31, 2024
Published Aug 26, 2024.
Settlement Jul 31, 2024
63,030 shares short
+27,300 shares (+76.4%) vs Jul 15, 2024
Published Aug 9, 2024.
Settlement Jul 15, 2024
35,730 shares short
+17,667 shares (+97.8%) vs Jun 28, 2024
Published Jul 24, 2024.
Settlement Jun 28, 2024
18,063 shares short
+12,009 shares (+198.4%) vs Jun 14, 2024
Published Jul 10, 2024.
Settlement Jun 14, 2024
6,054 shares short
-4,953 shares (-45%) vs May 31, 2024
Published Jun 26, 2024.
Settlement May 31, 2024
11,007 shares short
+4,727 shares (+75.3%) vs May 15, 2024
Published Jun 11, 2024.
Settlement May 15, 2024
6,280 shares short
-1,710 shares (-21.4%) vs Apr 30, 2024
Published May 24, 2024.
Settlement Apr 30, 2024
7,990 shares short
+6,499 shares (+435.9%) vs Apr 15, 2024
Published May 9, 2024.
Settlement Apr 15, 2024
1,491 shares short
-3,474 shares (-70%) vs Mar 28, 2024
Published Apr 24, 2024.
Settlement Mar 28, 2024
4,965 shares short
+1,253 shares (+33.8%) vs Mar 15, 2024
Published Apr 9, 2024.
Settlement Mar 15, 2024
3,712 shares short
-1,670 shares (-31%) vs Feb 29, 2024
Published Mar 26, 2024.
Settlement Feb 29, 2024
5,382 shares short
+2,329 shares (+76.3%) vs Feb 15, 2024
Published Mar 11, 2024.
Settlement Feb 15, 2024
3,053 shares short
+464 shares (+17.9%) vs Jan 31, 2024
Published Feb 27, 2024.
Settlement Jan 31, 2024
2,589 shares short
+1,781 shares (+220.4%) vs Jan 12, 2024
Published Feb 9, 2024.
Settlement Jan 12, 2024
808 shares short
-231 shares (-22.2%) vs Dec 29, 2023
Published Jan 24, 2024.
Settlement Dec 29, 2023
1,039 shares short
-1,635 shares (-61.1%) vs Dec 15, 2023
Published Jan 10, 2024.
Settlement Dec 15, 2023
2,674 shares short
-6,311 shares (-70.2%) vs Nov 30, 2023
Published Dec 26, 2023.
Settlement Nov 30, 2023
8,985 shares short
-849 shares (-8.6%) vs Nov 15, 2023
Published Dec 11, 2023.
Settlement Nov 15, 2023
9,834 shares short
+4,540 shares (+85.8%) vs Oct 31, 2023
Published Nov 24, 2023.
Settlement Oct 31, 2023
5,294 shares short
-4,692 shares (-47%) vs Oct 13, 2023
Published Nov 9, 2023.
Settlement Oct 13, 2023
9,986 shares short
+5,977 shares (+149.1%) vs Sep 29, 2023
Published Oct 24, 2023.
Settlement Sep 29, 2023
4,009 shares short
-3,064 shares (-43.3%) vs Sep 15, 2023
Published Oct 10, 2023.
Settlement Sep 15, 2023
7,073 shares short
-7,502 shares (-51.5%) vs Aug 31, 2023
Published Sep 26, 2023.
Settlement Aug 31, 2023
14,575 shares short
+1,981 shares (+15.7%) vs Aug 15, 2023
Published Sep 11, 2023.
Settlement Aug 15, 2023
12,594 shares short
-18,242 shares (-59.2%) vs Jul 31, 2023
Published Aug 24, 2023.
Settlement Jul 31, 2023
30,836 shares short
-2,159 shares (-6.5%) vs Jul 14, 2023
Published Aug 9, 2023.
Settlement Jul 14, 2023
32,995 shares short
+7,261 shares (+28.2%) vs Jun 30, 2023
Published Jul 25, 2023.
Settlement Jun 30, 2023
25,734 shares short
+4,563 shares (+21.6%) vs Jun 15, 2023
Published Jul 11, 2023.
Settlement Jun 15, 2023
21,171 shares short
-1,118 shares (-5%) vs May 31, 2023
Published Jun 26, 2023.
Settlement May 31, 2023
22,289 shares short
-11,810 shares (-34.6%) vs May 15, 2023
Published Jun 9, 2023.
Settlement May 15, 2023
34,099 shares short
-5,347 shares (-13.6%) vs Apr 28, 2023
Published May 24, 2023.
Settlement Apr 28, 2023
39,446 shares short
-33,387 shares (-45.8%) vs Apr 14, 2023
Published May 9, 2023.
Settlement Apr 14, 2023
72,833 shares short
+67,822 shares (+1,353.5%) vs Mar 31, 2023
Published Apr 25, 2023.
Settlement Mar 31, 2023
5,011 shares short
+3,110 shares (+163.6%) vs Mar 15, 2023
Published Apr 11, 2023.
Settlement Mar 15, 2023
1,901 shares short
-1,923 shares (-50.3%) vs Feb 28, 2023
Published Mar 24, 2023.
Settlement Feb 28, 2023
3,824 shares short
-62 shares (-1.6%) vs Feb 15, 2023
Published Mar 9, 2023.
Settlement Feb 15, 2023
3,886 shares short
-32,710 shares (-89.4%) vs Jan 31, 2023
Published Feb 24, 2023.
Settlement Jan 31, 2023
36,596 shares short
+30,501 shares (+500.4%) vs Jan 13, 2023
Published Feb 9, 2023.
Settlement Jan 13, 2023
6,095 shares short
-10,781 shares (-63.9%) vs Dec 30, 2022
Published Jan 24, 2023.
Settlement Dec 30, 2022
16,876 shares short
-3,115 shares (-15.6%) vs Dec 15, 2022
Published Jan 10, 2023.
Settlement Dec 15, 2022
19,991 shares short
+17,703 shares (+773.7%) vs Nov 30, 2022
Published Dec 26, 2022.
Settlement Nov 30, 2022
2,288 shares short
-10,290 shares (-81.8%) vs Nov 15, 2022
Published Dec 9, 2022.
Settlement Nov 15, 2022
12,578 shares short
-62,818 shares (-83.3%) vs Oct 31, 2022
Published Nov 24, 2022.
Settlement Oct 31, 2022
75,396 shares short
+50,251 shares (+199.8%) vs Oct 14, 2022
Published Nov 9, 2022.
Settlement Oct 14, 2022
25,145 shares short
Published Oct 25, 2022.
Settlement Sep 30, 2022
107,473 shares short
-59,512 shares (-35.6%) vs Sep 15, 2022
Published Oct 11, 2022.
Settlement Sep 15, 2022
166,985 shares short
+56,174 shares (+50.7%) vs Aug 31, 2022
Published Sep 26, 2022.
Settlement Aug 31, 2022
110,811 shares short
+97,430 shares (+728.1%) vs Aug 15, 2022
Published Sep 9, 2022.
Settlement Aug 15, 2022
13,381 shares short
-83,191 shares (-86.1%) vs Jul 29, 2022
Published Aug 24, 2022.
Settlement Jul 29, 2022
96,572 shares short
-61,565 shares (-38.9%) vs Jul 15, 2022
Published Aug 9, 2022.
Settlement Jul 15, 2022
158,137 shares short
-64,986 shares (-29.1%) vs Jun 30, 2022
Published Jul 26, 2022.
Settlement Jun 30, 2022
223,123 shares short
-38,906 shares (-14.8%) vs Jun 15, 2022
Published Jul 11, 2022.
Settlement Jun 15, 2022
262,029 shares short
+20,776 shares (+8.6%) vs May 31, 2022
Published Jun 24, 2022.
Settlement May 31, 2022
241,253 shares short
+183,056 shares (+314.5%) vs May 13, 2022
Published Jun 9, 2022.
Settlement May 13, 2022
58,197 shares short
-81,690 shares (-58.4%) vs Apr 29, 2022
Published May 24, 2022.
Settlement Apr 29, 2022
139,887 shares short
-148,884 shares (-51.6%) vs Mar 31, 2022
Published May 10, 2022.
Settlement Mar 31, 2022
288,771 shares short
-134,173 shares (-31.7%) vs Mar 15, 2022
Published Apr 11, 2022.
Settlement Mar 15, 2022
422,944 shares short
+26,136 shares (+6.6%) vs Feb 28, 2022
Published Mar 24, 2022.
Settlement Feb 28, 2022
396,808 shares short
-52,538 shares (-11.7%) vs Feb 15, 2022
Published Mar 9, 2022.
Settlement Feb 15, 2022
449,346 shares short
-316,148 shares (-41.3%) vs Jan 31, 2022
Published Feb 24, 2022.
Settlement Jan 31, 2022
765,494 shares short
-37,136 shares (-4.6%) vs Jan 14, 2022
Published Feb 9, 2022.
Settlement Jan 14, 2022
802,630 shares short
+265,722 shares (+49.5%) vs Dec 31, 2021
Published Jan 25, 2022.
Settlement Dec 31, 2021
536,908 shares short
+265,270 shares (+97.7%) vs Dec 15, 2021
Published Jan 11, 2022.
Settlement Dec 15, 2021
271,638 shares short
-108,091 shares (-28.5%) vs Nov 30, 2021
Published Dec 24, 2021.
Settlement Nov 30, 2021
379,729 shares short
+61,541 shares (+19.3%) vs Nov 15, 2021
Published Dec 9, 2021.
Settlement Nov 15, 2021
318,188 shares short
+61,566 shares (+24%) vs Oct 29, 2021
Published Nov 24, 2021.
Settlement Oct 29, 2021
256,622 shares short
-403,447 shares (-61.1%) vs Oct 15, 2021
Published Nov 9, 2021.
Settlement Oct 15, 2021
660,069 shares short
-112,476 shares (-14.6%) vs Sep 30, 2021
Published Oct 26, 2021.
Settlement Sep 30, 2021
772,545 shares short
-122,202 shares (-13.7%) vs Sep 15, 2021
Published Oct 11, 2021.
Settlement Sep 15, 2021
894,747 shares short
-49,755 shares (-5.3%) vs Aug 31, 2021
Published Sep 24, 2021.
Settlement Aug 31, 2021
944,502 shares short
-1,208,728 shares (-56.1%) vs Aug 13, 2021
Published Sep 9, 2021.
Settlement Aug 13, 2021
2,153,230 shares short
+1,309,792 shares (+155.3%) vs Jul 30, 2021
Published Aug 24, 2021.
Settlement Jul 30, 2021
843,438 shares short
-811,777 shares (-49%) vs Jul 15, 2021
Published Aug 10, 2021.
Settlement Jul 15, 2021
1,655,215 shares short
+218,752 shares (+15.2%) vs Jun 30, 2021
Published Jul 26, 2021.
Settlement Jun 30, 2021
1,436,463 shares short
+893,006 shares (+164.3%) vs Jun 15, 2021
Published Jul 9, 2021.
Settlement Jun 15, 2021
543,457 shares short
-2,390,341 shares (-81.5%) vs May 14, 2021
Published Jun 24, 2021.
Settlement May 14, 2021
2,933,798 shares short
+1,084,779 shares (+58.7%) vs Apr 30, 2021
Published May 25, 2021.
Settlement Apr 30, 2021
1,849,019 shares short
-270,409 shares (-12.8%) vs Apr 15, 2021
Published May 11, 2021.
Settlement Apr 15, 2021
2,119,428 shares short
+102,959 shares (+5.1%) vs Mar 31, 2021
Published Apr 26, 2021.
Settlement Mar 31, 2021
2,016,469 shares short
-247,666 shares (-10.9%) vs Mar 15, 2021
Published Apr 9, 2021.
Settlement Mar 15, 2021
2,264,135 shares short
+52,423 shares (+2.4%) vs Feb 26, 2021
Published Mar 24, 2021.
Settlement Feb 26, 2021
2,211,712 shares short
-243,028 shares (-9.9%) vs Jan 29, 2021
Published Mar 9, 2021.
Settlement Jan 29, 2021
2,454,740 shares short
+434,563 shares (+21.5%) vs Jan 15, 2021
Published Feb 9, 2021.
Settlement Jan 15, 2021
2,020,177 shares short
Published Jan 26, 2021.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records. Adjusted prices exclude a reused ticker’s earlier issuer. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
Through Nov 14, 2026
Recorded amounts and dates, not confirmation of cash received.
View all 2 splits
| Ex-date | Event | Recorded detail |
|---|---|---|
| Oct 11, 2022 | Reverse split | 1 for 12Each 12 pre-split shares become 1 post-split share. |
| Jan 24, 2018 | Reverse split | 1 for 30Each 30 pre-split shares become 1 post-split share. |
Cash bars retain the event's recorded currency and share basis. The yield line divides recorded cash in the preceding 365 days, adjusted for intervening splits, by a verified raw close in the same currency. Special dividends are included. Future ex-dates are excluded from yield. A split changes share count, not investment value. For long shares, past entitlement depends on when you held them; short shares can create a dividend payment obligation.
Source: recorded cash-dividend and split events.
Portfolio context
Link an account to see your stake, watchlist and past holdings.
We’ll show you if COCP is in your portfolio and how much it contributes.
Sign inMarket context
Smart money context
Holder IQ: MEDIUM
3 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Oct 27, 2026
Red flags
Red flags: 0
Largest 13-F holders · Q2 2026
26 filers reported a long position in COCP for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
91.7%
of the 1.1M shares 13-F filers reported
Moves vs Q1 2026
3 added2 trimmed
2 new · 3 unchanged
Net shares held
+26.3%
across the 8 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Vanguard Capital Management LLC | $376.1K · 358.2K shares | 358.2K | +49.3% |
| 2 | Renaissance Technologies LLC | $188.6K · 179.6K shares | 179.6K | +44.9% |
| 3 | Two Sigma Investments, LP | $184.1K · 175.4K shares | 175.4K | New |
| 4 | Geode Capital Management, LLC | $80K · 76.2K shares | 76.2K | -15.5% |
| 5 | BlackRock, Inc. | $77.4K · 73.7K shares | 73.7K | Unchanged |
| 6 | Citadel Advisors LLC | $47.4K · 45.1K shares | 45.1K | New |
| 7 | Neuberger Berman Group LLC | $33.5K · 31.9K shares | 31.9K | Unchanged |
| 8 | XTX Topco Ltd | $30.8K · 29.3K shares | 29.3K | -18.6% |
| 9 | Jane Street Group, LLC | $27K · 25.8K shares | 25.8K | +102.7% |
| 10 | Vanguard Fiduciary Trust Co | $25.2K · 24K shares | 24K | Unchanged |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of COCP file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Nov 6, 2026 | Opko Health Inc13D · activist · amended | 29.6% |
| Aug 7, 2026 | Frost Phillip MD Et Al13D · activist · amended | 13.9% |
Moves the factor model did not explain
How much of COCP’s move accompanied the market and its measured style leanings, and how much was left? The residual is unexplained by this fitted model. It does not establish a cause, skill or future alpha.
Return split unavailable. A complete, reconciled model for every market session in this window is unavailable. Missing dates are not filled.
Link an account with dated transactions to see what share of your own holding’s move since its purchase-date close was unexplained, with long and short positions distinguished. Your private holdings never enter this public chart.
Dated model observations (20)
Daily percentage returns, not window contributions. Source: the same dated warehouse rows and model v1.2.0; observed 2026-11-14T15:52:51.264Z. Absent sessions are never interpolated; missing or failed inputs stay unavailable.
| Date | Stock | Market | Styles | Residual |
|---|---|---|---|---|
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable |
How this split is calculated
Each day uses that day’s fitted market intercept and style exposures multiplied by that day’s published factor returns. Their sum plus the independently stored residual must reconcile to the stock return. Window effects are weighted by stock wealth at each day’s start and added; the stock return compounds. Every expected US market session must be present and pass source, identity, model and numerical checks. This retrospective fit is an explanation of measured returns, not evidence of causation or an investable forecast. The window ends at the latest published model session, which can lag the market; today’s unfinished session is excluded.
What insiders reported owning
Reading dated filing evidence…
Get the Full Analysis for COCP
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.